CD4 and melanoma: On the other hand, the three-round oncolytic therapy of melanoma pulmonary-lesion-bearing mice showed increased (borderline) animal survival (p = 0.0485), upregulated expression of genes encoding pro-inflammatory cytokines, and markers for infiltrating immune effector T cells (CD4 and CD8), which points to the activation of antitumor immune response.